
ALT Preprint posted April 5, 2024: "Increased fibrinaloid microclot counts in platelet-poor plasma are associated with Long COVID" Abstract: "...The pathophysiology underlying Long COVID remains unclear but appears to involve multiple mechanisms including persistent inflammation, coagulopathy, autoimmunity, and organ damage. Studies suggest that microclots, also known as fibrinaloids, play a role in Long COVID. In this context, we developed a method to quantify microclots and investigated the relationship between microclot counts and Long COVID. We show that as a cohort, platelet-poor plasma from Long COVID samples had a higher microclot count compared to control groups but retained a wide distribution of counts. ... Our findings suggest that microclots could be a potential biomarker of disease and/or a treatment target in some Long COVID patients."








